
Sign up to save your podcasts
Or


In this episode of Data in Biotech, Ross Katz sits down with Kyle Smith and Jacob Mayer from Aprecia Pharmaceuticals to explore how 3D printing is transforming pharmaceutical manufacturing. They dive into the unique binder jetting process, in-cavity printing, and how real-time data and automation are enabling agile, scalable, and precise drug production. Discover how Aprecia's approach is changing the game for clinical trials and personalized medicine.
What you'll learn in this episode:
>> How Aprecia developed the world’s first FDA-approved 3D printed drug
>> Why binder jetting stands out among 3D printing methods in pharma
>> How in-cavity 3D printing enables real-time tablet-level data collection
>> The future of closed-loop control and digital twins in drug manufacturing
>> Why 3D printing is key to agile, distributed, and personalized pharma production
Meet our guests:
Kyle Smith is President and COO of Aprecia Pharmaceuticals, leading strategic growth and innovation in GMP-regulated pharma manufacturing. With 12+ years at Aprecia, he brings deep expertise in engineering, operations, and technology transfer.
Jacob Mayer is Director of Engineering Innovation at Aprecia Pharmaceuticals. With a decade of experience across automation, additive manufacturing, and life sciences, he leads the advancement of 3D printing technologies and integrated pharma systems.
About the host
Ross Katz is Principal and Data Science Lead at CorrDyn. Ross specializes in building intelligent data systems that empower biotech and healthcare organizations to extract insights and drive innovation.
Connect with our guests:
Connect with us:
Sponsored by…
This episode is brought to you by CorrDyn, the leader in data-driven solutions for biotech and healthcare. Discover how CorrDyn is helping organizations turn data into breakthroughs at CorrDyn.
By CorrDyn5
1010 ratings
In this episode of Data in Biotech, Ross Katz sits down with Kyle Smith and Jacob Mayer from Aprecia Pharmaceuticals to explore how 3D printing is transforming pharmaceutical manufacturing. They dive into the unique binder jetting process, in-cavity printing, and how real-time data and automation are enabling agile, scalable, and precise drug production. Discover how Aprecia's approach is changing the game for clinical trials and personalized medicine.
What you'll learn in this episode:
>> How Aprecia developed the world’s first FDA-approved 3D printed drug
>> Why binder jetting stands out among 3D printing methods in pharma
>> How in-cavity 3D printing enables real-time tablet-level data collection
>> The future of closed-loop control and digital twins in drug manufacturing
>> Why 3D printing is key to agile, distributed, and personalized pharma production
Meet our guests:
Kyle Smith is President and COO of Aprecia Pharmaceuticals, leading strategic growth and innovation in GMP-regulated pharma manufacturing. With 12+ years at Aprecia, he brings deep expertise in engineering, operations, and technology transfer.
Jacob Mayer is Director of Engineering Innovation at Aprecia Pharmaceuticals. With a decade of experience across automation, additive manufacturing, and life sciences, he leads the advancement of 3D printing technologies and integrated pharma systems.
About the host
Ross Katz is Principal and Data Science Lead at CorrDyn. Ross specializes in building intelligent data systems that empower biotech and healthcare organizations to extract insights and drive innovation.
Connect with our guests:
Connect with us:
Sponsored by…
This episode is brought to you by CorrDyn, the leader in data-driven solutions for biotech and healthcare. Discover how CorrDyn is helping organizations turn data into breakthroughs at CorrDyn.

32,245 Listeners

7,807 Listeners

4,181 Listeners

113,290 Listeners

56,909 Listeners

126 Listeners

337 Listeners

4,855 Listeners

34 Listeners

566 Listeners

2,055 Listeners

5,598 Listeners

151 Listeners

21 Listeners

62 Listeners